DRUGS related term(s) Crime

Addresses

Joint Meeting of Congress: Vicente Fox, President of Mexico, H5411 [6SE]

Amendments

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (H.R. 3129), H10067 [13DE]

National Alcohol and Drug Addiction Recovery Month: designate (S. Res. 147), S9859, S9933 [26SE]

Pharmaceuticals: improve safety and efficacy for children (S. 838), S10816, S10844, S10848 [18OC]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), S13997 [20DE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (S. 1715), S13907 [20DE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (S. 1765), S13060 [12DE]

Analyses

Child Protection/Alcohol and Drug Partnership Act (S. 484), S1996 [7MR]

21st Century Law Enforcement, Crime Prevention, and Victims Assistance Act (S. 16), S214-S220 [22JA]

Appointments

Conferees: H.R. 3448, Bioterrorism Preparedness Act, S13911 [20DE]

Parent Advisory Council on Youth Drug Abuse, S5802 [26MY]

Articles and editorials

Add Gun Buybacks to the Public Wish List, S8651 [2AU]

Chronicle of a Massacre Foretold, E89-E91 [1FE]

Colombia—Military Links to Paramilitary Groups Persist, H4465 [24JY]

County Juggles Marijuana Policies in Mendocino, It's Citizens vs. DEA, H4192 [18JY]

Day in the Life, H3460 [21JN]

Dead Wrong on AIDS, E1164 [20JN]

Despite Legal Victory, South Africa Hesitates on AIDS Drugs, H1528 [24AP]

Dogs of War Bare Their Teeth Over Colombia, E1366 [18JY]

Global AIDS Strategy May Prove Elusive—More Funds Available, but Consensus Lacking, H1529 [24AP]

Gun Buy-Back Backfires When Officers Cash In, S8652 [2AU]

HHS Set To Order Smallpox Vaccine for All Americans, S11751 [14NO]

High-Tech Stealth Being Used To Sway Doctor Prescriptions, E1422 [25JY]

How $40 Million More Can Aid Addicts, H3191 [14JN]

Leading Young Leaders, H3459 [21JN]

Learn From Haiti, H9105 [11DE]

Longer Lines for Flu Shots—Increase Attributed in Part to Anxiety About Anthrax, S11991 [16NO]

Lure of Ecstasy, H3194-H3196 [14JN]

Madness of Gun Buybacks—Andrew Cuomo's Policy Is Full of Holes, S8652 [2AU]

Missionary Says Drug Surveillance Should Resume Quickly, H1695 [1MY]

Now Is the Time, S1319 [13FE]

Raids Reveal Fake Homes Filled With Marijuana Farms, H4191 [18JY]

Specialists Cool on Calls To Revive Gun Buybacks, S8651 [2AU]

Spend Colombia Money at Home, E1420 [25JY]

Teen Challenge's Newest Challenge, H3458 [21JN]

Tijuana Streets Teem With Addicted Youths, H7714 [1NO]

Vt. Teen's Death Ruled Homicide, S1320 [13FE]

Bills and resolutions

Afghanistan: make assistance conditional upon undertaking efforts to control illegal drugs (see H.R. 3556), H10963 [20DE]

Animals: increase the availability of drugs for minor species and rare diseases in all animals (see H.R. 1956), H2678 [23MY]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (see S. 754), S3706 [6AP] (see H.R. 1063), H953 [15MR] (see H.R. 1530), H1498 [4AP]

Bush, President: commend upcoming trip to Mexico to meet with President Vicente Fox and encourage future cooperative efforts between the U.S. and Mexico (see S. Con. Res. 13), S1395 [14FE] (see H. Con. Res. 35), H399 [14FE]

Children and youth: amend certain laws relative to pediatric studies of drugs (see H.R. 3047), H6379 [4OC]

———meet mental health and substance abuse treatment needs of incarcerated children and youth (see H.R. 2198), H3202 [14JN]

Consumers: correct impediments to allowing importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use (see H.R. 58), H26 [3JA]

———discrepancy in prescription drug prices between U.S. and foreign countries (see H. Res. 26), H166 [31JA]

———permit individuals to import prescription drugs in limited circumstances (see S. 1229), S8123 [24JY]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans (see S. 104), S100 [22JA] (see H.R. 1111), H1011 [20MR]

Correctional institutions: authorize funding for successful reentry of criminal offenders into local communities (see S. 194), S636 [29JA]

———establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors (see S. 317), S1270 [13FE] (see H.R. 2580), H4377 [20JY]

———increase monitoring of inmate conversations to detect and deter crimes committed by inmates using Federal telephones (see H.R. 45), H26 [3JA]

———jail-based substance abuse treatment programs funding (see S. 146), S456 [23JA]

Courts: concentrate Federal resources on the prosecution of major drug offenses (see H.R. 1978), H2679 [23MY]

———death penalty sentencing for certain importations of significant quantities of controlled substances (see H.R. 213), H62 [6JA]

———reduce disparity in penalties for crack and powder cocaine offenses and focus drug sentencing on seriousness of offense and culpability of offender (see S. 1874), S13943 [20DE]

Crack cocaine: eliminate certain mandatory minimum penalties for offenses (see H.R. 697), H397 [14FE]

Crime: improve capacity and commitment of local communities to prevent and reduce crime, violence, and substance abuse (see H.R. 3579), H10964 [20DE]

———national policy to control crime and reform court procedures (see S. 16), S97 [22JA]

———prevent juvenile crime, promote accountability, rehabilitate juvenile offenders, and punish and deter violent gang crime (see S. 1165), S7494 [11JY]

———provide penalties for open air drug markets (see H.R. 417), H219 [7FE]

———reduce criminal gang activities (see S. 1236), S8203 [25JY]

Cuba: lift travel restrictions and certain trade sanctions (see S. 239), S1012 [1FE]

———make exception to trade embargo for food, medicines, and goods and services intended for children, lift travel restrictions, and provide scholarships for certain Cuban nationals (see S. 1017), S6127 [12JN] (see H.R. 2138), H3067 [12JN]

Customs Service: authorizing appropriations for personnel and technology to reduce delays at border crossings and strengthen drug enforcement (see S. 92), S100 [22JA] (see S. 1031), S6212 [13JN] (see H.R. 2512), H4111 [17JY]

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (see H.R. 3129), H6918 [16OC]

Dept. of HHS: establish Office of Correctional Health (see H.R. 2422), H3805 [28JN]

———prepare and publish annually a consumer guide to prescription drug prices (see H.R. 2660), H4724 [26JY]

Dept. of Veterans Affairs: authorize projects to facilitate the treatment of veterans with Alzheimer's disease (see H. Res. 29), H221 [7FE]

———standardize copayment exemption levels for outpatient medications (see S. 1408), S9197 [6SE]

———suspend authority to increase copayment for medication furnished on an outpatient basis for treatment of service-connected disabilities (see H.R. 2671), H4779 [27JY] (see H.R. 2820), H5337 [2AU]

Developing countries: prohibit export assistance to any company challenging an intellectual property law or policy of a country that regulates HIV/AIDS pharmaceuticals or medical technologies (see H.R. 1690), H1860 [2MY]

———prohibit revocation or revision of any intellectual property or competition law or policy in any country that regulates HIV/AIDS pharmaceuticals or medical technologies (see H.R. 1185), H1113 [22MR]

Diseases: expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (see S. 1230), S8123 [24JY]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (see S. 463), S1897 [6MR] (see H.R. 933), H740 [7MR] (see H.R. 2069), H2955 [6JN]

Drug abuse: combat trafficking, distribution, and abuse of ``Ecstasy'' and other club drugs (see S. 1208), S7955 [19JY] (see H.R. 2582), H4377 [20JY]

———establish a club drug task force and authorize grants to expand prevention efforts regarding the abuse of club drugs (see H.R. 3138), H6918 [16OC]

———provide assistance to States to expand and establish treatment programs to provide services to individuals who voluntarily seek treatment (see H.R. 1896), H2333 [17MY]

———reduce illegal drug use and trafficking and help provide appropriate drug education, prevention and treatment programs (see S. 304), S1270 [13FE]

FDA: establish restrictions relative to the qualifications of physicians prescribing the abortion drug known as RU-486 (see S. 251), S1062 [6FE] (see H.R. 482), H221 [7FE]

———grant authority to regulate tobacco (see S. 190), S568 [25JA] (see S. 247), S1062 [6FE] (see H.R. 1043), H953 [15MR] (see H.R. 1097), H1010 [20MR] (see H.R. 2180), H3201 [14JN]

———permit import of prescription medications sold in certain foreign countries and correct impediments in implementation of the Medicine Equity and Drug Safety Act (see S. 215), S707 [30JA]

———require manufacturers of dietary supplements to register and require submission of reports on adverse experiences regarding such supplements (see H.R. 3065), H6458 [9OC]

Federal aid programs: public participation in establishing locations of substance abuse treatment group homes (see H.R. 2844), H5454 [6SE]

Federal employees: require preemployment drug testing (see H.R. 197), H62 [6JA]

Federal Food, Drug, and Cosmetic Act: amend relative to clinically superior modifications to previously approved or licensed drugs (see H.R. 386), H165 [31JA]

———amend relative to new animal drugs (see S. 1346), S8705 [2AU]

———provide greater access to affordable pharmaceuticals (see S. 812), S4100 [1MY] (see H.R. 1862), H2280 [16MY]

FEMA: develop a plan for stockpiling potassium iodide tablets in areas near nuclear powerplants (see H.R. 783), H506 [28FE]

Foreign aid: applicability of drug certification procedures to countries which have certain agreements with the U.S. relative to counterdrug activities (see S. 435), S1747 [1MR]

———suspend drug certification procedures of the Foreign Assistance Act in order to foster greater multilateral cooperation in international counternarcotics programs (see S. 219), S707 [30JA]

Foreign Assistance Act: improve immunization injection safety in disease control programs (see H.R. 2453), H3861 [10JY]

———suspend drug certification procedures in order to foster greater multilateral cooperation in international counternarcotics programs (see H.R. 841), H622 [1MR]

Foreign countries: modify the procedures relating to assistance for countries not cooperating in U.S. counterdrug efforts (see S. 376), S1463 [15FE]

Foreign policy: eliminate authority for Federal employees and agents to assist foreign countries with drug interdiction activities of suspected aircraft (see H.R. 1818), H2141 [10MY]

Foreign trade: encourage the U.S. Trade Representative to investigate price controls imposed by Mexico and Canada on prescription drugs (see H. Con. Res. 126), H1924 [3MY]

Government: prohibit financing for nongovernmental organizations or individuals to carry out military, law enforcement, armed rescue, or other related operations in the Andean region, including narcotics control efforts (see H.R. 1591), H1604 [25AP]

Government regulations: establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors (see H.R. 3066), H6458 [9OC]

———regulate receipt of donated prescription drug samples by charitable health care entities (see H.R. 2740), H5334 [2AU]

Hazardous substances: prevent inhalant abuse (see H.R. 790), H506 [28FE]

Health: allow access to drugs and medical devices recommended and provided by health care practitioners that are not approved by the FDA (see S. 1378), S8911 [3AU] (see H.R. 1964), H2678 [23MY]

———availability of influenza vaccine (see H.R. 943), H825 [8MR]

———conduct oversight hearings to determine the causes and outcomes surrounding the influenza vaccine shortage (see H. Res. 11), H28 [3JA]

———emergency distributions of influenza vaccine (see H.R. 910), H739 [7MR]

———establish compulsory licensing of certain patented medical inventions (see H.R. 3235), H7852 [6NO]

———improve access to prescription drugs under Medicare and the Federal Food, Drug, and Cosmetic Act, and health care coverage for seniors, the self-employed, and children (see H.R. 1387), H1481 (see H.R. 1387), H1491 [4AP]

———use of marijuana for medicinal purposes (see H.R. 1344), H1407 [3AP] (see H.R. 2592), H4428 [23JY]

Higher Education Act: repeal provisions prohibiting persons convicted of drug offenses from receiving student financial assistance (see H.R. 786), H506 [28FE]

Insurance: provide equitable coverage of mental health, substance abuse, and chemical dependency treatment services under group and individual health coverage (see H.R. 162), H61 [6JA]

———provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (see S. 595), S2730 [22MR] (see H.R. 1194), H1114 [22MR]

———require comprehensive coverage for childhood immunizations (see S. 1297), S8575 [1AU] (see H.R. 580), H323 [13FE]

Iraq: provide citizens access to U.S. food and medicines (see H.R. 742), H441 [27FE]

Law enforcement: enhance illegal narcotics control activities (see S. 89), S99 [22JA]

———promote rural safety and improve rural law enforcement (see S. 1763), S12369 [4DE] (see S. 1787), S12682 [7DE]

Law enforcement officers: tribute for efforts in battling the use and production of methamphetamine (see H. Res. 114), H1487 (see H. Res. 114), H1499 [4AP]

Medicaid: clarify Dept. of HHS authority to treat certain State prescription drug discount demonstration projects as medical assistance for purposes of rebate agreements (see S. 1177), S7589 [12JY] (see H.R. 2513), H4111 [17JY]

———coverage of all medically necessary services for uninsured families and individuals (see H.R. 2627), H4633 [25JY]

———permit children covered under the State Children's Health Insurance Program to be eligible for the Federal Vaccines for Children Program (see S. 573), S2582 [20MR] (see H.R. 2701), H5125 [1AU]

———permit uninsured individuals to obtain coverage to assure coverage of prescription drugs, substance abuse treatment, mental health services, and long-term care services (see H.R. 1142), H1059 [21MR]

———require States that provide prescription drug coverage to cover drugs that treat obesity (see H.R. 1641), H1659 [26AP]

Medicare: coverage of certain beta interferons and other biologicals and drugs for treatment of multiple sclerosis (see H.R. 1758), H2021 [8MY]

———coverage of home infusion drug therapies (see H.R. 2750), H5334 [2AU]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant (see S. 1204), S7955 [19JY]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant without regard to when the transplant was received (see H.R. 2057), H2888 [5JN]

———coverage of nursing facilities and in-home services (see H.R. 913), H739 [7MR]

———coverage of oral anticancer drugs (see S. 913), S5118 [17MY] (see H.R. 1624), H1659 [26AP]

———coverage of oral drugs to reduce serum phosphate levels in patients with end stage renal disease (see S. 1304), S8703 [2AU] (see H.R. 3246), H7909 [7NO]

———coverage of oral drugs to treat low blood calcium levels or elevated parathyroid hormone levels for patients with end stage renal disease (see H.R. 121), H59 [6JA]

———coverage of outpatient prescription drugs (see S. 10), S97 [22JA] (see S. 925), S5438 [22MY] (see S. 1185), S7805 [17JY] (see S. Res. 74), S3922 [25AP] (see H.R. 339), H163 [31JA] (see H.R. 1512), H1498 [4AP] (see H.R. 1905), H2333 [17MY] (see H.R. 2632), H4633 [25JY]

———coverage of pharmacist services (see S. 974), S5694 [25MY] (see H.R. 2799), H5336 [2AU]

———coverage of self-administered drugs that, when used as a replacement for covered drugs, result in overall cost savings to the program (see H.R. 3317), H8337 [16NO]

———establish voluntary outpatient prescription drug coverage program (see S. 1263), S8353 [27JY]

———establish voluntary outpatient prescription drug discount and security program (see S. 1239), S8203 [25JY]

———expand coverage of certain self-injected biologicals (see S. 554), S2388 [15MR] (see H.R. 1089), H959 [19MR]

———expand coverage of preventive services and provide coverage of outpatient prescription drugs (see H.R. 828), H622 [1MR]

———extend coverage of immunosuppressive drugs to cases of transplants not paid for under the program (see H.R. 3032), H6379 [4OC]

———improve payments and regulation under the Medicare+Choice program (see H.R. 3584), H10964 [20DE]

———make more competitive and efficient, extend solvency, provide a prescription drug benefit, improve quality of care, and make Medigap insurance more affordable (see H.R. 803), H507 [28FE]

———make more competitive and efficient and provide for a prescription drug benefit (see S. 357, 358), S1463 [15FE]

———promote research for health promotion and disease prevention and add preventive benefits (see S. 982), S5830 [5JN] (see H.R. 2058), H2888 [5JN]

———provide adequate coverage of immunosuppressive drugs for certain kidney transplant patients (see S. 880), S4939 [15MY] (see H.R. 1839), H2183 [15MY]

———reductions in prescription drug prices (see S. 125), S100 [22JA] (see S. 699), S3436 [4AP] (see H.R. 1400), H1482 (see H.R. 1400), H1491 [4AP]

———reductions in prescription drug prices for beneficiaries and women with breast cancer (see H.R. 758), H442 [27FE]

———reform (see S. 1135), S7084 [28JN]

Mexico: grant a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts (see S. 353), S1462 [15FE] (see H.R. 753), H441 [27FE]

Montana: designate certain counties as High Intensity Drug Trafficking Areas and authorize funding for drug control activities in those areas (see S. 715), S3530 [5AP]

Motor vehicles: prohibit operation with drugs or alcohol in the body of the driver at a land border port of entry (see H.R. 2155), H3149 [13JN]

National Alcohol and Drug Addiction Recovery Month: designate (see S. Res. 147), S8705 [2AU]

———observance (see H. Con. Res. 190), H4428 [23JY]

National Guard: authorize the operation of counterdrug schools (see S. 374), S1463 [15FE]

National Inhalants and Poisons Awareness Week: designate (see S. Res. 43), S1817 [5MR]

National objectives: extend and modify the Drug-Free Communities Support Program and authorize a National Community Antidrug Coalition Institute (see S. 1075), S6518 [20JN] (see H.R. 2291), H3465 [21JN]

National Vaccine Injury Compensation Program: amend (see H.R. 1287), H1343 [29MR]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (see S. 210), S706 [30JA]

NIH: biomedical research funding (see S. Res. 19), S1271 [13FE] (see H. Res. 72), H507 [28FE]

NRC: ensure that sufficient stockpiles of potassium iodide tablets have been established near nuclear power plants and that appropriate plans for their utilization exist (see H.R. 3279), H8132 [13NO]

NSF: establish grants to encourage research and development programs in plant biotechnology (see H.R. 2912), H5925 [21SE]

Office of National Drug Control Policy: enter into negotiations with Cuban Government representatives to provide for increased cooperation on drug interdiction efforts (see H.R. 1124), H1011 [20MR]

Pharmaceuticals: ensure prompt research, development, and distribution of new drugs, biologics, and medical devices that prevent or mitigate the consequences of a chemical or biological terrorist attack (see S. 1635), S11488 [6NO] (see H.R. 3457), H9239 [11DE]

———establish compulsory licensing of certain patented prescription drugs and medical inventions (see H.R. 1708), H1923 [3MY]

———establish therapeutic equivalence requirements for generic drugs (see H.R. 1685), H1860 [2MY]

———expand human clinical trials qualifying for the orphan drug tax credit (see S. 1341), S8704 [2AU] (see H.R. 1298), H1344 [29MR]

———importation of certain prescription drugs by pharmacists and wholesalers (see H.R. 698), H397 [14FE]

———improve safety and efficacy for children (see S. 838), S4416 [7MY] (see S. 1301), S8575 [1AU] (see S. 1789), S12682 [7DE] (see H.R. 2887), H5615 [13SE] (see H.R. 3452), H9239 [11DE]

———provide access and choice for use of generic drugs under Federal health care programs (see S. 186), S568 [25JA]

———provide for prices that are fair to the producer and the consumer (see H.R. 1574), H1555 [24AP]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 2801), H5337 [2AU]

Prescription drugs: distribution chain (see S. 1132), S7083 [28JN] (see H.R. 68), H26 [3JA]

Public Health Service Act: amend relative to pharmacy health professions programs (see S. 1806), S12859 [11DE] (see H.R. 2173), H3201 [14JN]

Public housing: reduce crime and fully fund the Public Housing Drug Elimination Program (see S. Con. Res. 52), S6602 [21JN]

Red Ribbon Week: support goals (see H. Con. Res. 84), H1189 [27MR]

Research: prohibit federally sponsored research pertaining to the legalization of drugs (see H.R. 196), H62 [6JA]

Safe and Drug-Free Schools and Communities Act: provide comprehensive technical assistance and implement highly effective prevention programs (see H.R. 970), H827 [8MR]

———revise and extend (see S. 437), S1747 [1MR]

SBA: extend authorization of the Drug-Free Workplace Program (see S. 348), S1462 [15FE]

Schools: allow certain grants to be used to establish and maintain school safety hotlines (see H.R. 899), H649 [6MR]

———enhance safety (see H.R. 1812), H2141 [10MY]

———expulsion of students for possession of guns or illegal drugs (see S. 79), S99 [22JA]

Ships and vessels: provide for the stockpiling of potassium iodide tablets in areas near the homeport of nuclear powered naval vessels (see H.R. 3510), H10355 [18DE]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (see S. 484), S1971 [7MR] (see H.R. 1909), H2334 [17MY]

Sports: prohibit gambling on high school and college sports and the Olympics and establish NIST grant program to fund detection and prevention of the use of performance-enhancing drugs (see S. 718), S3530 [5AP]

States: expand and establish drug abuse treatment programs to enable such programs to provide services to individuals who voluntarily seek treatment for drug abuse (see S. 160), S456 [23JA] (see S. 843), S4508 [8MY]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 383), H165 [31JA] (see H.R. 1127), H1011 [20MR]

———allow designation of income tax refunds for use in NIH biomedical research programs (see H.R. 1340), H1407 [3AP]

———allow drug manufacturers a tax credit if they certify that the price of a drug in the U.S. is not greater than its price in Canada or Mexico (see H.R. 946), H826 [8MR]

———allow Medicare beneficiaries a refundable credit for purchase of outpatient prescription drugs (see S. 1600), S11286 [31OC]

———reduce the per dose tax on vaccines (see S. 459), S1897 [6MR] (see H.R. 921), H740 [7MR]

———treatment of certain gifts and benefits provided to physicians by prescription drug manufacturers (see H.R. 2641), H4634 [25JY]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (see H.R. 2352), H3712 [27JN]

———treatment of foods and supplements for dietary use, and medical foods as medical expenses (see S. 1330), S8704 [2AU] (see H.R. 3475), H10055 [12DE]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack (see S. 1715), S11940 [15NO] (see S. 1765), S12369 [4DE] (see H.R. 3310), H8336 [16NO] (see H.R. 3448), H9239 [11DE]

———protect children (see S. 1539), S10640 [11OC] (see S. 1685), S11789 [14NO] (see H.R. 3106), H6701 [11OC]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological or chemical weapons attack (see S. 1764), S12369 [4DE]

Veterans: exempt prescription drugs and medical supplies dispensed by Dept. of Veterans Affairs pharmacies from interest and administrative cost charges (see H.R. 890), H649 [6MR]

Women: study approved drugs for whether their use affects women differently than men (see H.R. 2783), H5336 [2AU]

Descriptions

Criminal Gang Abatement Act (S. 1236), S8212 [25JY]

Public Health Security and Bioterrorism Response Act (H.R. 3448), E2387-E2389 [20DE]

Factsheets

AIDS Epidemic Update: WHO, H9098-H9104 [11DE]

AIDS/HIV Facts and Figures, E1058 [7JN]

Alternative Economic Development and Resettlement, H618 [1MR]

Child Protection/Alcohol and Drug Partnership Act (S. 484), S1995 [7MR]

Letters

Aerial spraying efforts to eradicate illicit crops in Colombia: Rafael Orduz, Colombian Senate, H4517 [24JY]

District of Columbia needle exchange programs: A. Cornelius Baker, Whitman-Walker Clinic, Inc., S11513 [7NO]

———Michael Kelly, District of Columbia Housing Authority, S11513 [7NO]

———Mohammad N. Akhter, American Public Health Association, S11513 [7NO]

———Paola Barahona, Prevention Works (organization), S11514 [7NO]

Drug-Free Communities Support Program extension and modification and National Community Antidrug Coalition Institute authorization: Representative Burton, Committee on Government Reform (House), H5348 [5SE]

———Representative Tauzin, Committee on Energy and Commerce (House), H5348 [5SE]

Foreign aid eligibility relative to counter-drug certification process: Paul V. Kelly, Dept. of State, H10444 [19DE]

Importation of prescription drugs into the U.S. by U.S. citizens for personal use: William B. Simpkins, DEA, H3892, H3895 [11JY]

———William K. Hubbard, FDA, H3893 [11JY]

Investigation into Bristol-Myers Squibb, Inc., representation of average wholesale prices of prescription drugs relative to Medicare reimbursement: Representative Stark, E244 [28FE]

Public Health Security and Bioterrorism Response Act: Representative Boehlert, Committee on Science (House), H9210 [11DE]

———Representative Tauzin, Committee on Energy and Commerce (House), H9210 [11DE]

Public Housing Drug Elimination Program funding: Terri Hamilton Brown, Cuyahoga Metropolitan Housing Authority, E1478 [31JY]

Supreme Court decision on use of marijuana for medicinal purposes: Representatives Souder, Barr and Ose, H4191 [18JY]

Lists

Supporters of S. 843, Treatment on Demand Assistance Act, S4514 [8MY]

Supporters of S. 982, Medicare Wellness Act, S5834 [5JN]

Memorandums

Approval of Generic Versions of Drugs Without Pediatric Labeling, H10209 [18DE]

———Laurence H. Tribe, E2286-E2288 [13DE]

———Wilmer, Cutler & Pickering (law firm), H8106 [13NO]

Messages

National Emergency Relative to Narcotics Traffickers in Colombia: President Bush, S10792 [17OC], H7112 [17OC]

Outlines

Biological and Chemical Weapons Countermeasures Research Act (S. 1764), S12384 [4DE]

Poems

``Fence or an Ambulance,'' Joseph Malins, S4386 [4MY]

Proclamations

Voluntary Medicare Outpatient Prescription Drug Discount and Security Program: National Pharmaceutical Association, E1631 [11SE]

Remarks in House

AID: South Asian Office of Foreign Disaster Assistance funding through reductions in Andean Counterdrug Initiative funding, H4449-H4453 [24JY]

Al-Anon Family Groups, Inc.: anniversary, E1588 [5SE]

Andean Counterdrug Initiative: funding, H7560 [31OC], H7713 [1NO]

Animals: increase the availability of drugs for minor species and rare diseases in all animals (H.R. 1956), E904 [23MY]

Armed Forces: assignment of personnel to assist the INS and Customs Service with border control activities, H6020-H6022, H6050-H6053 [25SE], H6568 [11OC]

Asia: assistance to Islamic extremist groups by central Asian nations, E585 [5AP]

Bolivia: drug interdiction operations funding, H4478, H4479 [24JY]

Bristol-Myers Squibb, Inc.: investigation into representation of average wholesale prices of prescription drugs relative to Medicare reimbursement, E244 [28FE]

Children and youth: meet mental health and substance abuse treatment needs of incarcerated children and youth (H.R. 2198), E1111 [14JN]

Chile: approval of certain abortifacients, E1000 [5JN]

Colombia: counternarcotics operations, H155-H158 [31JA]

———drug interdiction assistance, H4341, H4343, H4346 [19JY], H5779 [20SE], E1366 [18JY], E1420 [25JY], E1441 [26JY]

———human rights violations, E89 [1FE]

———limit U.S. civilian contractors relative to anti-drug efforts, H4498-H4501 [24JY]

———prohibit aerial spraying efforts to eradicate illicit crops, H4515-H4519 [24JY]

Colorado: results of 4th Congressional District constituent survey on national issues, E105 [6FE]

Consumers: allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use, H3598 [26JN], H3624 [27JN], H3756 [28JN], H3880-H3889 [11JY], E1345 [17JY]

———allow importation of prescription drugs into the U.S. by U.S. citizens for personal use, H3494 [25JN], H3789 [28JN], H3871, H3890-H3897 [11JY], E1345 [17JY]

———discrepancy in prescription drug prices between U.S. and foreign countries, H1837-H1841 [2MY], H3598 [26JN], H3624 [27JN], H3756 [28JN], H3851-H3858 [10JY]

———discrepancy in prescription drug prices between U.S. and foreign countries (H. Res. 26), E98 [1FE]

———require the U.S. Trade Representative to enter into negotiations to eliminate price controls imposed by certain foreign countries on prescription drugs, E704 [2MY]

Contraceptives: eliminate coverage for women in Federal health insurance plans and freeze family planning programs funding, H1608 [26AP]

Correctional institutions: establish grants for drug treatment alternatives to prison programs administered by State or local prosecutors, H3190 [14JN]

Crime: combat manufacture, traffic, import, and export of methamphetamine, H4086 [17JY], H4199 [18JY]

Customs Service, Office of the U.S. Trade Representative, and ITC: authorizing appropriations (H.R. 3129), H8952, H8960-H8971 [6DE]

DEA: enforcement of Controlled Substances Act relative to assisted suicide and euthanasia, H7786 [6NO]

Dept. of Defense: counterdrug programs reorganization, H5781 [20SE]

———transfer of Tethered Aerostat Radar System to the Customs Service for counterdrug activities, H5781 [20SE]

Dept. of HHS: prepare and publish annually a consumer guide to prescription drug prices (H.R. 2660), E1440 [26JY]

Dept. of HUD: Public Housing Drug Elimination Grant Program funding, H4672, H4674 [26JY]

———Public Housing Drug Elimination Program funding through reductions in HOME Investment Partnerships Program and home ownership downpayment assistance, H4730-H4742 [27JY]

Dept. of Justice: Community Oriented Policing Services methamphetamine production and trafficking prevention funding through reductions in International Broadcasting Operations, H4091, H4092 [17JY], E1417 [24JY]

Dept. of Veterans Affairs: authorize projects to facilitate the treatment of veterans with Alzheimer's disease, H4696 [26JY]

———authorize projects to facilitate the treatment of veterans with Alzheimer's disease (H. Res. 29), E112 [6FE]

———suspend authority to increase copayment for medication furnished on an outpatient basis for treatment of service-connected disabilities (H.R. 2820), H8848, H8890 [5DE], H10951 [20DE]

Developing countries: prohibit revocation or revision of any intellectual property or competition law or policy in any country that regulates HIV/AIDS pharmaceuticals or medical technologies, H8979 [6DE]

Diseases: AIDS epidemic, H2864-H2866, H2870, H2876-H2884 [5JN], H3839-H3851 [10JY], E1002, E1005, E1017 [5JN], E1035, E1036 [6JN], E1045, E1057 [7JN], E1142 [19JN], E1261 [29JN], E1405 [24JY]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, E1877 [12OC]

———Global AIDS Trust Fund funding through reductions in the Andean Counterdrug Initiative funding and the Foreign Military Financing Program, H4455-H4464 [24JY], E1429 [25JY]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries, H813 [8MR], H904 [14MR], H995-H1003 [20MR], H1528-H1530 [24AP], H1562 [25AP], H1848-H1855 [2MY], H2255 [16MY], H3688 [27JN]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (H.R. 2069), H9089-H9106 [11DE], E1026 [6JN], E2273 [13DE], E2327 [19DE]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (H.R. 933), H997 [20MR], E400 [20MR]

———improve access to HIV/AIDS-related treatments and services in the Caribbean nations, E1261 [29JN], E1403 [24JY]

———improve diagnosis and treatment of HIV/AIDS in women and children, H908 [14MR]

———safety of certain medications approved for use by diabetes patients, E2207 [5DE]

———State AIDS Drug Assistance Programs funding through reductions in other AIDS-related services funding, H6647-H6649 [11OC]

District of Columbia: prohibit needle exchange programs funding, H9051, H9052 [6DE]

Drug abuse: Dept. of Justice grant to ``Race Against Drugs'' substance abuse prevention education program, H79 [30JA]

———national drug control policy, H510, H614 [1MR], H654 [7MR], H3189-H3194 [14JN], H3495 [25JN], H7327-H7329 [25OC]

Ecuador: counternarcotics operations, H155-H158 [31JA]

FDA: approval of the abortion drug known as RU-486, E123 [6FE]

———food safety programs for foodborne threats funding through reductions in Medicine Equity and Drug Safety Act funding, H3918 [11JY]

———grant authority to regulate tobacco (H.R. 1097), H914-H918 [14MR]

———grant authority to regulate tobacco (H.R. 2180), E1117 [14JN]

———Office of Generic Drugs funding, H3778, H3779 [28JN]

———prohibit funding to prevent importation into the U.S. of certain approved drugs, H3690 [27JN]

———reallocation of funding to the Office of Generic Drugs to evaluate and review potential patent abuses, H3919-H3921 [11JY]

———require manufacturers of dietary supplements to register and require submission of reports on adverse experiences regarding such supplements (H.R. 3065), E1833 [9OC]

———require new drug applications include a statement specifying the total cost of research and development, H3921 [11JY]

Federal Employees Health Benefits Program: coverage of contraceptives under any plan providing prescription drug coverage, H4562 [25JY], H7542 [31OC]

Foreign aid: Caribbean and South American nations drug interdiction assistance funding, H4342 [19JY]

———suspend drug certification procedures of the Foreign Assistance Act in order to foster greater multilateral cooperation in international counternarcotics programs, H10460 [19DE]

Foreign Assistance Act: suspend drug certification procedures in order to foster greater multilateral cooperation in international counternarcotics programs, H7560 [31OC]

Foreign policy: modify authorities relative to interdiction of aircraft engaged in drug trafficking, H6391, H6393 [5OC]

Gannet (vessel): commissioning of Coast Guard cutter, E1449 [26JY]

Government regulations: establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids and prohibit sales of such supplements to minors (H.R. 3066), E1833 [9OC]

Haiti: U.S. policy, E2084 [15NO]

Hazardous substances: recall and suspend use of vaccines containing mercury and certain other chemical substances, H10206 [18DE]

Health: improve access to prescription drugs under Medicare and the Federal Food, Drug, and Cosmetic Act, and health care coverage for seniors, the self-employed, and children (H.R. 1387), H1474 [4AP], H1834 [2MY]

———prohibit funding to prevent certain States from implementing laws allowing the use of marijuana for medicinal purposes, H4190-H4193 [18JY]

Hear O' Israel International, Inc.: dedication of Listen to the Cries of the Children National Campaign, E1798 [4OC]

Insurance: comprehensive coverage for childhood immunizations funding, H10433 [19DE]

———provide equitable coverage of mental health, substance abuse, and chemical dependency treatment services under group and individual health coverage (H.R. 162), H615 [1MR]

———require comprehensive coverage for childhood immunizations (H.R. 580), E163 [13FE]

Jacobus Pharmaceutical Co.: tribute, E1351 [18JY]

Kennesaw, GA: observance of Power Team Week, E886 [22MY]

Lafayette, NJ: anniversary of Sunrise House Halfway Home, E486 [29MR]

Medicaid: permit children covered under the State Children's Health Insurance Program to be eligible for the Federal Vaccines for Children Program (H.R. 2701), E1509 [2AU]

———require States that provide prescription drug coverage to cover drugs that treat obesity (H.R. 1641), E660 [26AP]

Medicare: coverage of outpatient prescription drugs, H309-H311 [13FE], H820 [8MR], H1160, H1175 [27MR], H1471-H1475 [4AP], H1507-H1515 [24AP], H1575, H1594, H1596 [25AP], H1702, H1705, H1707 [1MY], H1835-H1842 [2MY], H2005 [8MY], H2862, H2866-H2870 [5JN], H3032-H3038 [12JN], H3690 [27JN], H5383 [5SE]

———coverage of outpatient prescription drugs (H.R. 2632), H6413 [5OC]

———promote research for health promotion and disease prevention and add preventive benefits (H.R. 2058), E1008, E1017 [5JN]

———protection of certain trust funds in coverage of outpatient prescription drugs, H1507-H1515 [24AP]

———reductions in prescription drug prices for beneficiaries and women with breast cancer (H.R. 758), H1110 [22MR]

———reductions in prescription drug prices (H.R. 1400), H1584, H1587 [25AP], H1838 [2MY], H2867 [5JN], E1315 [11JY]

———reimbursement of prescription drug costs at the average wholesale price, E44 [30JA]

Minorities: impact of HIV/AIDS epidemic, E1079 [12JN]

Narco Freedom, Inc.: anniversary, E2199 [4DE]

National Alcohol and Drug Addiction Recovery Month: observance (H. Con. Res. 190), H4809-H4811 [30JY], E1588 [5SE]

National Hispanic Science Network on Drug Abuse: tribute to Hispanic Drug Abuse Research conference, H7856 [7NO]

National objectives: extend and modify the Drug-Free Communities Support Program and authorize a National Community Antidrug Coalition Institute (H.R. 2291), H5345-H5353 [5SE]

National security: ensure adequate personnel and technology to protect borders, H7709-H7715 [1NO]

———ensure adequate personnel and technology to protect the Northern border, H8632 [29NO]

National Vaccine Injury Compensation Program: amend (H.R. 1287), E488 [29MR]

Natsios, Andrew S.: statement on prevention and treatment of AIDS in Africa, E1164 [20JN]

Nigeria: allocation of foreign aid, H4330 [19JY]

NIH: biomedical research funding, E449 [27MR]

NSF: establish grants to encourage research and development programs in plant biotechnology, E1678 [20SE]

Office of National Drug Control Policy: High Intensity Drug Trafficking Areas funding through reductions in IRS taxpayer refund notification funding, H3331-H3335 [20JN]

Office of the U.S. Trade Representative: prohibit funding to initiate World Trade Organization proceedings challenging policies in developing countries relative to HIV/AIDS pharmaceuticals, H4178-H4187 [18JY], E1420 [25JY]

Peru: involvement of the CIA in the shooting down of an aircraft carrying missionaries, H1563 [25AP]

———make Andean Counterdrug Initiative funding contingent on report on missionary aircraft mistakenly shot down by a Peruvian fighter jet and notification of U.S. involvement in counternarcotic flights, H4501 [24JY]

———U.S. policy on drug interdiction, E750 [8MY]

Pharmaceuticals: approval of generic versions of drugs without pediatric labeling relative to exclusive marketing rights agreements, H8551 [28NO], H10209 [18DE], E2286 [13DE]

———dangers of antibiotic-resistant pathogens, H7392 [30OC], H7561 [31OC], H7726 [6NO]

———expand human clinical trials qualifying for the orphan drug tax credit (H.R. 1298), E488 [29MR]

———improve safety and efficacy for children (H.R. 2887), H7562 [31OC], H7727 [6NO], H8094-H8107 [13NO], H8166 [14NO], H8551 [28NO], E2073 [14NO], E2103 [15NO], E2114 [16NO], E2286 [13DE]

———improve safety and efficacy for children (S. 1789), H10200-H10212 [18DE], E2368, E2389 [20DE]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 2801), E1537, E1542 [3AU]

———reinstate reasonable pricing requirements for drugs developed with Federal funding or research, H6666 [11OC], E1881 [12OC]

———relationship between medical research institutes and for-profit companies relative to NIH research money and drug prices, H170 [6FE]

Prescription drugs: distribution chain (H.R. 68), E2 [3JA]

Red Ribbon Week: support goals, E2255 [12DE]

———support goals (H. Con. Res. 84), H5963, H5964 [24SE]

Republican Party: national agenda, H1016 [21MR]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (H.R. 1909), E844 [17MY]

South America: impact of free trade on drug interdiction efforts, H8253-H8257, H8259, H8260, H8289, H8291-H8294, H8296 [16NO]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (H.R. 1127), H961 [20MR]

———allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (H.R. 383), E94 [1FE]

———allow drug manufacturers a tax credit if they certify that the price of a drug in the U.S. is not greater than its price in Canada or Mexico (H.R. 946), E317 [8MR]

———treatment of certain gifts and benefits provided to physicians by prescription drug manufacturers (H.R. 2641), E1421 [25JY]

———treatment of direct-to-consumer advertisements of prescription drugs that fail to provide certain information to the consumer (H.R. 2352), E1225 [27JN]

———treatment of foods and supplements for dietary use, and medical foods as medical expenses (H.R. 3475), E2288 [13DE], E2293 [14DE]

Terrorism: improve the ability of the U.S. to prepare for and respond to a biological threat or attack, H8239-H8243 [15NO]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), H9195-H9217, H9232-H9234 [11DE], E2270, E2272, E2285 [13DE], E2387, E2410 [20DE]

———protect children (H.R. 3106), E1866 [12OC]

———use of illegal drug money to fund terrorist activities, H6462 [10OC]

Tobacco products: tobacco industry liability settlement relative to health risks and marketing and manufacturing practices, H4002-H4006 [12JY]

Treaties and agreements: impact of free trade on drug prices, H8999 [6DE]

U.N.: prohibit International Narcotics Control Board funding, H4524-H4526 [24JY]

U.N. Drug Control Program: funding, E759 [8MY]

Veterans: exempt prescription drugs and medical supplies dispensed by Dept. of Veterans Affairs pharmacies from interest and administrative cost charges (H.R. 890), E290 [6MR]

Walters, John P.: nomination to be Office of National Drug Control Policy Director, E776 [10MY]

Washington: Northeast Washington State Four County Methamphetamine Task Force funding, H4199 [18JY]

WHYI-Radio (Miami, FL): tribute to fundraising efforts to benefit young people with drug addictions, H6462 [10OC]

Remarks in Senate

Al-Anon Family Groups, Inc.: anniversary, S9193 [6SE]

Andean Counterdrug Initiative: economic and social development programs funding, S10954-S10956 [24OC]

———require additional condition for procurement of chemicals for aerial coca fumigation, S10939-S10943 [24OC]

Antitrust policy: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs (S. 754), S3760 [6AP]

Barthwell, Andrea G.: nomination to be Office of National Drug Control Policy Deputy Director for Demand Reduction, S13355 [17DE]

Beaulac, Tim: Pharmacist of the Year award recipient, S6444 [19JN]

Budget: allocation of funds, S3227-S3230 [30MR]

Bush, President: commend upcoming trip to Mexico to meet with President Vicente Fox and encourage future cooperative efforts between the U.S. and Mexico (S. Con. Res. 13), S1435-S1437 [14FE]

Center Point, Inc.: anniversary, S11609 [8NO]

Centers for Disease Control and Prevention: smallpox vaccination for first responders funding, S13786 [20DE]

Children and youth: provide assistance to local education agencies to reduce and prevent underage drinking, S4385, S4386 [4MY]

Coast Guard: aircraft and vessel modernization funding, S6053 [11JN]

———establish Maritime Security Teams and make changes in personnel to prevent terrorism, work in drug interdiction, and improve marine safety, S13883 [20DE]

Colombia: condition military assistance upon certification of efforts to eliminate drug production and combat human rights abuses, S10965 [24OC]

———drug interdiction assistance, S10929-S10938 [24OC]

Consumers: allow importation of prescription drugs into the U.S. by pharmacists and wholesalers for resale and by U.S. citizens for personal use, S7440 [11JY], S7871 [18JY], S11071 [25OC]

———discrepancy in prescription drug prices between U.S. and foreign countries, S7871 [18JY], S11071 [25OC]

———permit individuals to import prescription drugs in limited circumstances (S. 1229), S8131 [24JY]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans (S. 104), S375-S377 [22JA]

Correctional institutions: authorize funding for successful reentry of criminal offenders into local communities (S. 194), S638 [29JA]

———jail-based substance abuse treatment programs funding (S. 146), S457 [23JA]

Courts: reduce disparity in penalties for crack and powder cocaine offenses and focus drug sentencing on seriousness of offense and culpability of offender (S. 1874), S13961-S13965 [20DE]

Crime: combat manufacture, traffic, import, and export of methamphetamine, S9379-S9381 [13SE]

———national policy to control crime and reform court procedures (S. 16), S220-S222 [22JA]

———prevent juvenile crime, promote accountability, rehabilitate juvenile offenders, and punish and deter violent gang crime (S. 1165), S7499-S7516 [11JY]

———reduce criminal gang activities (S. 1236), S8207-S8210 [25JY]

Cuba: lift travel restrictions and certain trade sanctions (S. 239), S1014, S1015 [1FE]

———make exception to trade embargo for food, medicines, and goods and services intended for children, lift travel restrictions, and provide scholarships for certain Cuban nationals (S. 1017), S6135, S6136 [12JN]

Customs Service: aircraft and vessel modernization funding, S6053 [11JN]

———authorizing appropriations for personnel and technology to reduce delays at border crossings and strengthen drug enforcement (S. 92), S356 [22JA]

DEA: enforcement of Controlled Substances Act relative to assisted suicide and euthanasia, S11564 [7NO]

———tribute to efforts to combat interational drug trafficking, S5825 [5JN]

Democratic Party: national agenda, S10865, S10866 [23OC]

Dept. of Defense: drug interdiction and counterdrug activities funding, S7873 [18JY], S8695 [2AU]

Dept. of HUD: Public Housing Drug Elimination Program gun buyback initiatives funding, S8643-S8645, S8647-S8653, S8655, S8656 [2AU]

Dept. of Justice: status of tobacco industry lawsuit relative to health risks and marketing and manufacturing practices, S9367 [13SE]

Dept. of Veterans Affairs: standardize copayment exemption levels for outpatient medications (S. 1408), S9198 [6SE]

Diseases: AIDS epidemic, S5821-S5825 [5JN], S6886 [26JN]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis (S. 1230), S8132 [24JY]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries, S3479-S3481, S3520 [5AP], S6886 [26JN]

———improve access to HIV/AIDS-related treatments and services in sub-Saharan Africa and other developing countries (S. 463), S1902 [6MR]

District of Columbia: needle exchange programs funding, S12583 [7DE]

———prohibit needle exchange programs funding, S11507-S11515 [7NO]

Drug abuse: combat ``Ecstasy'' production, abuse, and imports, and increase education and awareness on dangers, S5262 [21MY]

———combat trafficking, distribution, and abuse of ``Ecstasy'' and other club drugs (S. 1208), S7966 [19JY]

———national drug control policy, S13355 [17DE]

———reduce illegal drug use and trafficking and help provide appropriate drug education, prevention and treatment programs (S. 304), S1314-S1321 [13FE], S8458 [31JY]

———treatment and rehabilitation programs, S13355 [17DE]

Ecuador: counternarcotics operations, S6917 [26JN]

Education: expand alternative education options for certain disruptive students, S6174-S6176 [13JN]

FDA: dietary supplement regulations enforcement funding, S11092-S11094 [25OC], S11272 [31OC]

———educational activities for senior citizens relative to generic drugs funding, S11191 [30OC]

———grant authority to regulate tobacco (S. 247), S1063 [6FE], S2972 [27MR]

———permit import of prescription medications sold in certain foreign countries and correct impediments in implementation of the Medicine Equity and Drug Safety Act (S. 215), S775 [30JA], S7440 [11JY]

———response to shortage of betamethasone drugs relative to premature delivery of babies, S5528 [23MY]

Federal Employees Health Benefits Program: coverage of contraceptives under any plan providing prescription drug coverage, S9495 [19SE]

Federal Food, Drug, and Cosmetic Act: amend relative to new animal drugs (S. 1346), S8768 [2AU]

Foreign aid: applicability of drug certification procedures to countries which have certain agreements with the U.S. relative to counterdrug activities (S. 435), S1770 [1MR]

———Caribbean and South American nations drug interdiction strategy, S4883 [14MY], S6053 [11JN]

———suspend drug certification procedures of the Foreign Assistance Act in order to foster greater multilateral cooperation in international counternarcotics programs, S13900 [20DE]

———suspend drug certification procedures of the Foreign Assistance Act in order to foster greater multilateral cooperation in international counternarcotics programs (S. 219), S782-S784 [30JA], S9151-S9153 [6SE]

Foreign Assistance Act: suspend drug certification procedures in order to foster greater multilateral cooperation in international counternarcotics programs, S10957, S10958 [24OC]

Foreign countries: modify the procedures relating to assistance for countries not cooperating in U.S. counterdrug efforts (S. 376), S1521 [15FE]

Garza, Juan R.: execution in Federal capital case, S6440, S6441 [19JN]

Health: allow access to drugs and medical devices recommended and provided by health care practitioners that are not approved by the FDA (S. 1378), S8951 [3AU]

———availability of influenza vaccine, S11990, S11991 [16NO]

Homeless: substance abuse prevention and treatment services funding, S11347 [1NO]

Insurance: provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (S. 595), S2732 [22MR]

———require comprehensive coverage for childhood immunizations (S. 1297), S8593 [1AU]

Law enforcement: enhance illegal narcotics control activities (S. 89), S347 [22JA]

———promote rural safety and improve rural law enforcement (S. 1763), S12375 [4DE]

———promote rural safety and improve rural law enforcement (S. 1787), S12684 [7DE]

———tribute to various agencies for drug interdiction efforts, S3782 [23AP]

Medicaid: clarify Dept. of HHS authority to treat certain State prescription drug discount demonstration projects as medical assistance for purposes of rebate agreements (S. 1177), S7594, S7595 [12JY]

———permit children covered under the State Children's Health Insurance Program to be eligible for the Federal Vaccines for Children Program (S. 573), S2588 [20MR]

Medicare: coverage of oral anticancer drugs (S. 913), S5125, S5126 [17MY]

———coverage of oral drugs to reduce serum phosphate levels in patients with end stage renal disease (S. 1304), S8710 [2AU]

———coverage of outpatient prescription drugs, S1167 [8FE], S1669, S1671 [28FE], S2576 [20MR], S3298-S3326 [3AP], S3474 [5AP], S3666 [6AP], S4789 [10MY], S5083-S5086 [17MY], S5249 [21MY], S5505 [23MY]

———coverage of outpatient prescription drugs (S. 10), S155 [22JA]

———coverage of outpatient prescription drugs (S. 925), S5444-S5447 [22MY], S8153 [25JY]

———coverage of outpatient prescription drugs (S. 1185), S7718 [16JY], S7809, S7818 [17JY]

———coverage of outpatient prescription drugs (S. Res. 74), S3927 [25AP]

———coverage of pharmacist services (S. 974), S5706 [25MY]

———expand coverage of certain self-injected biologicals (S. 554), S2409 [15MR]

———make more competitive and efficient and provide for a prescription drug benefit (S. 357), S1500 [15FE]

———make more competitive and efficient and provide for a prescription drug benefit (S. 358), S1500 [15FE]

———promote research for health promotion and disease prevention and add preventive benefits (S. 982), S5833-S5836 [5JN]

———provide adequate coverage of immunosuppressive drugs for certain kidney transplant patients (S. 880), S4942 [15MY]

———reductions in prescription drug prices (S. 125), S401 [22JA]

———reductions in prescription drug prices (S. 699), S3451 [4AP], S8394 [30JY]

———reform (S. 1135), S7107 [28JN]

Mexico: drug interdiction strategy, S9151-S9153 [6SE]

———extradition of Everardo A.P. Martinez, S4585 [9MY]

———grant a temporary waiver of requirements relative to foreign aid certification of drug enforcement efforts (S. 353), S1495 [15FE]

Missouri: Missouri Drug Eradication Initiative funding, S9379, S9380 [13SE]

Montana: designate certain counties as High Intensity Drug Trafficking Areas and authorize funding for drug control activities in those areas (S. 715), S3541 [5AP]

National Alcohol and Drug Addiction Recovery Month: designate (S. Res. 147), S8770 [2AU], S9859 [26SE]

National Guard: authorize the operation of counterdrug schools (S. 374), S1517, S1518 [15FE]

———Counterdrug Program funding, S9066 [4SE]

———tribute to personnel for drug interdiction efforts, S4036 [30AP]

National Inhalants and Poisons Awareness Week: designate (S. Res. 43), S1828 [5MR]

National objectives: extend and modify the Drug-Free Communities Support Program and authorize a National Community Antidrug Coalition Institute (H.R. 2291), S9410 [13SE], S12216 [29NO]

———extend and modify the Drug-Free Communities Support Program and authorize a National Community Antidrug Coalition Institute (H.R. 2291), unanimous-consent agreement, S9412 [14SE]

———extend and modify the Drug-Free Communities Support Program and authorize a National Community Antidrug Coalition Institute (S. 1075), S6526-S6530 [20JN]

Native Americans: authorize the integration and consolidation of alcohol and substance abuse programs and services provided by tribal governments (S. 210), S714 [30JA]

NIH: biomedical research funding, S3392 [4AP], S6565 [21JN]

———biomedical research funding (S. Res. 19), S1352 [13FE]

Novartis Pharmaceuticals Corp.: tribute to CardCare discount drug program for senior citizens, S11784 [14NO]

Office of National Drug Control Policy: release of report on drug usage and availability in the U.S., S4413 [7MY]

Organization for Security and Cooperation in Europe: congressional delegation trip to parliamentary assembly in France, S7944 [19JY]

Peru: counternarcotics operations, S6917 [26JN]

Pharmaceuticals: expand human clinical trials qualifying for the orphan drug tax credit (S. 1341), S8762 [2AU]

———improve safety and efficacy for children (S. 838), S4422-S4425 [7MY], S10816-S10819, S10826-S10831 [18OC], S10871-S10873 [23OC]

———improve safety and efficacy for children (S. 1301), S8597-S8599 [1AU]

———improve safety and efficacy for children (S. 1789), S12752 [7DE], S12755 [10DE], S13070 [12DE]

———provide access and choice for use of generic drugs under Federal health care programs (S. 186), S572 [25JA], S8394 [30JY]

Prescription drugs: distribution chain (S. 1132), S7104 [28JN]

Public Health Service Act: amend relative to pharmacy health professions programs (S. 1806), S12863 [11DE]

Safe and Drug-Free Schools and Communities Act: revise and extend (S. 437), S1772 [1MR]

SBA: extend authorization of the Drug-Free Workplace Program (S. 348), S1479 [15FE]

Schools: ensure safety through prevention and intervention programs, S4475 [8MY]

———expulsion of students for possession of guns or illegal drugs (S. 79), S332, S335, S423 [22JA]

Social Security: create a grant program to promote joint activities between Federal, State, and local child welfare and alcohol and drug abuse prevention and treatment agencies (S. 484), S1994-S1998 [7MR]

Sports: prohibit gambling on high school and college sports and the Olympics and establish NIST grant program to fund detection and prevention of the use of performance-enhancing drugs (S. 718), S3543, S3544 [5AP]

States: expand and establish drug abuse treatment programs to enable such programs to provide services to individuals who voluntarily seek treatment for drug abuse (S. 160), S497 [23JA]

———expand and establish drug abuse treatment programs to enable such programs to provide services to individuals who voluntarily seek treatment for drug abuse (S. 843), S4512 [8MY]

Substance Abuse and Mental Health Services Administration: release of study on adolescent drug use, S6513 [20JN]

Surgeon General: release of ``Women and Smoking'' report, S2972 [27MR]

Taxation: allow Medicare beneficiaries a refundable credit for purchase of outpatient prescription drugs (S. 1600), S11288 [31OC]

———treatment of foods and supplements for dietary use, and medical foods as medical expenses (S. 1330), S8751 [2AU]

Terrorism: antitrust exemption for agreements reached with parties involved in the development of bioterrorism countermeasures, S13903 [20DE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), S13868, S13900, S13902-S13911, S13933, S14030 [20DE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (H.R. 3448), unanimous-consent agreement, S13868 [20DE]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (S. 1715), S11951-S11956 [15NO], S11996 [16NO], S12034-S12036 [27NO]

———improve the ability of the U.S. to prepare for and respond to a biological threat or attack (S. 1765), S12386 [4DE], S12389 [5DE]

———protect children from bioterrorism, S10871-S10873 [23OC]

———protect children (S. 1539), S10649 [11OC]

———protect children (S. 1685), S11791-S11794 [14NO]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological or chemical weapons attack (S. 1764), S12376-S12384 [4DE]

Walters, John P.: confirmation as Office of National Drug Control Policy Director, S12531 [6DE]

———evaluation of priorities as Office of National Drug Control Policy Director, S13355 [17DE]

———nomination to be Office of National Drug Control Policy Director, S4818 [10MY], S8534 [1AU], S8899-S8901 [3AU], S11425 [5NO], S12029 [27NO], S12119-S12121 [29NO], S12439-S12443 [5DE]

———nomination to be Office of National Drug Control Policy Director, unanimous-consent agreement, S12271 [30NO]

Washington: Washington State Methamphetamine Program funding, S9380, S9381 [13SE]

Reports

Liver Failure Risk for Diabetes Patients Taking Rezulin: David J. Graham and Lanh Green, E2207-E2209 [5DE]

Reports filed

Amateur Sports Integrity Act: Committee on Commerce, Science, and Transportation (Senate) (S. 718) (S. Rept. 107-16), S4890 [14MY]

Best Pharmaceuticals for Children Act: Committee on Energy and Commerce (House) (H.R. 2887) (H. Rept. 107-277), H8034 [9NO]

———Committee on Health, Education, Labor, and Pensions (Senate) (S. 838) (S. Rept. 107-79), S10286 [4OC]

Customs Border Security Act: Committee on Ways and Means (House) (H.R. 3129) (H. Rept. 107-320), H8947 [5DE]

Drug Abuse Education, Prevention, and Treatment Act: Committee on the Judiciary (Senate) (S. 304), S12160 [29NO]

Drug-Free Communities Support Program Extension and Modification and National Community Antidrug Coalition Institute Authorization: Committee on Government Reform (House) (H.R. 2291) (H. Rept. 107-175), H4862 [30JY]

Flu Vaccine Availability Act: Committee on Energy and Commerce (House) (H.R. 943) (H. Rept. 107-168), H4723 [26JY]

Global Access to HIV/AIDS Prevention, Awareness, Education, and Treatment Act: Committee on International Relations (House) (H.R. 2069) (H. Rept. 107-137), H4008 [12JY]

Nomination of John P. Walters To Be Office of National Drug Control Policy Director: Committee on the Judiciary (Senate), S11611 [8NO]

Support Goals of Red Ribbon Week: Committee on Energy and Commerce (House) (H. Con. Res. 84) (H. Rept. 107-197), H5404 [5SE]

Suspend Foreign Assistance Act Drug Certification Procedures in Order To Foster Greater Multilateral Cooperation in International Counternarcotics Programs: Committee on Foreign Relations (Senate) (S. 219), S3529 [5AP]

Resolutions by organizations

Hear O' Israel International, Inc., Listen to the Cries of the Children National Campaign: Lee P. Brown, Mayor of Houston, TX, and Houston, TX, City Council, E1798 [4OC]

Statements

Cannabis Legalization: Josh Smolkin, E1706 [24SE]

Impact of Illegal Drugs on Colombia: Andres Pastrana, President of Colombia, H618 [1MR]

Nomination of John P. Walters To Be Office of National Drug Control Policy Director: John P. Walters, E777 [10MY]

———President Bush, E776 [10MY]

Summaries

Bioterrorism Preparedness Act (S. 1715), S11952 [15NO]

Counternarcotics Operations in Putumayo, Colombia, H156 [31JA]

Drug Abuse Education, Prevention, and Treatment Act (S. 304), S1315-S1317 [13FE]

Drug Competition Act (S. 754), S3761 [6AP]

Kids and Terrorism Preparedness Act (S. 1685), S11792 [14NO]

Meet Mental Health and Substance Abuse Treatment Needs of Incarcerated Children and Youth (H.R. 2198), E1111 [14JN]

National Youth Smoking Reduction Act (H.R. 2180), E1118 [14JN]

Public Health Security and Bioterrorism Response Act (H.R. 3448), H9211 [11DE]

Tables

Drug price comparison, H3495 [25JN]

Estimated cost to consumers of exclusivity extensions for certain pediatric drugs, H8102 [13NO]

HIV/AIDS statistics, H1000 [20MR]

12th graders drug use, S13964 [20DE]

U.N. Drug Control Program pledges from individual nations, E760 [8MY]

Testimonies

Drug Abuse Education, Prevention, and Treatment Act: Carroll O'Connor, S8459 [31JY]

Texts of

H. Con. Res. 84, support goals of Red Ribbon Week, H5964 [24SE]

H. Con. Res. 190, National Alcohol and Drug Addiction Recovery Month, H4809 [30JY]

H.R. 2069, Global Access to HIV/AIDS Prevention, Awareness, Education, and Treatment Act, H9089-H9093 [11DE]

H.R. 2291, Drug-Free Communities Support Program extension and modification and National Community Antidrug Coalition Institute authorization, H5345-H5347 [5SE]

H.R. 2887, Best Pharmaceuticals for Children Act, H8094-H8098 [13NO]

H.R. 3129, Customs Border Security Act, H8960-H8965 [6DE]

H.R. 3448, Public Health Security and Bioterrorism Response Act, H9195-H9209 [11DE]

S. 10, Medicare Prescription Drug Coverage Act, S155-S163 [22JA]

S. 16, 21st Century Law Enforcement, Crime Prevention, and Victims Assistance Act, S164-S214 [22JA]

S. 79, Safe Schools Act, S334 [22JA]

S. 89, Drug-Free America Act, S347-S355 [22JA]

S. 146, jail-based substance abuse treatment programs funding, S458 [23JA]

S. 186, Generic Pharmaceutical Access and Choice for Consumers Act, S573 [25JA]

S. 194, Offender Reentry and Community Safety Act, S639-S643 [29JA]

S. 210, Native American Alcohol and Substance Abuse Program Consolidation Act, S714 [30JA]

S. 215, Medication Equity and Drug Savings Act, S776 [30JA]

S. 219, suspend drug certification procedures of the Foreign Assistance Act in order to foster greater multilateral cooperation in international counternarcotics programs, S783 [30JA]

S. 239, Cuba Food and Medicine Access Act, S1014 [1FE]

S. 247, Kids Deserve Freedom From Tobacco Act, S1063-S1066 [6FE]

S. 348, Drug-Free Workplace Program Extension Act, S1479 [15FE]

S. 374, National Guard operation of counterdrug schools, S1517 [15FE]

S. 376, modify the procedures relating to assistance for countries not cooperating in U.S. counterdrug efforts, S1521 [15FE]

S. 437, Safe and Drug-Free Schools and Communities Act, S1772-S1778 [1MR]

S. 463, Global Access to AIDS Treatment Act, S1903 [6MR]

S. 595, Fairness in Treatment—The Drug and Alcohol Addition Recovery Act, S2733-S2735 [22MR]

S. 699, Prescription Drug Fairness for Seniors Act, S3451 [4AP]

S. 838, Best Pharmaceuticals for Children Act, S4422-S4424 [7MY]

S. 843, Treatment on Demand Assistance Act, S4513 [8MY]

S. 880, Immunosuppressive Drug Coverage Act, S4943 [15MY]

S. 925, Medicare Extension of Drugs to Seniors (MEDS) Act, S5447-S5455 [22MY]

S. 1075, Drug-Free Communities Support Program extension and modification and National Community Antidrug Coalition Institute authorization, S6527-S6529 [20JN]

S. 1165, Juvenile Crime Prevention and Control Act, S7500-S7515 [11JY]

S. 1185, Seniors Prescription Insurance Coverage Equity (SPICE) Act, S7809-S7818 [17JY]

S. 1236, Criminal Gang Abatement Act, S8210-S8212 [25JY]

S. 1239, Medicare Rx Drug Discount and Security Act, S8216-S8222 [25JY]

S. 1330, Dietary Supplement Tax Fairness Act, S8751 [2AU]

S. 1341, expand human clinical trials qualifying for the orphan drug tax credit, S8763 [2AU]

S. 1408, Veterans' Copayment Adjustment Act, S9199 [6SE]

S. 1539, Protecting America's Children Against Terrorism Act, S10650-S10652 [11OC]

S. 1635, Pathogen Research, Emergency Preparedness and Response Efforts (PREPARE) Act, S11489-S11491 [6NO]

S. 1685, Kids and Terrorism Preparedness Act, S11792 [14NO]

S. 1787, Rural Safety Act, S12684 [7DE]

S. 1789, Best Pharmaceuticals for Children Act, S13071-S13076 [12DE], H10200-H10204 [18DE]

S. 1806, Pharmacy Education Aid Act, S12863 [11DE]

S. Con. Res. 13, commend President Bush's upcoming trip to Mexico to meet with President Vicente Fox and encourage future cooperative efforts between the U.S. and Mexico, S1428 [14FE]

S. Con. Res. 52, reduce crime and fully fund the Public Housing Drug Elimination Program, S6620 [21JN]

S. Res. 19, NIH biomedical research funding, S1351 [13FE]

S. Res. 43, National Inhalants and Poisons Awareness Week, S1828 [5MR]

S. Res. 74, Medicare coverage of outpatient prescription drugs, S3927 [25AP]

S. Res. 147, National Alcohol and Drug Addiction Recovery Month, S8770 [2AU], S10024 [1OC]